Bristol-Myers Squibb | Ventes



Sales Changement Date
AbbVie USD 15.42B 2.08B 2025-06
Abbott USD 11.42B 1.06B 2025-06
ALKERMES USD 390.7M 84.2M 2025-06
Amgen USD 9.18B 1.03B 2025-06
AstraZeneca USD 14.46B 867M 2025-06
Biogen USD 2.6B 170M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 15.56B 2.83B 2025-06
Gilead Sciences USD 7.1B 430M 2025-06
GlaxoSmithKline GBP 7.99B 470M 2025-06
J&J USD 23.74B 1.85B 2025-06
Medtronic USD 8.6B 330M 2025-06
Merck USD 15.81B 280M 2025-06
Novartis USD 14.05B 821M 2025-06
Novo Nordisk 76.86B 1.23B 2025-06
Perrigo USD 1.06B 20M 2025-06
Pfizer USD 14.7B 980M 2025-06
Prestige Brands USD 249.53M 46.99M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.99B 90M 2025-06
Sanofi EUR 11.26B 3.5B 2024-12
United Therapeutics USD 798.6M 4.2M 2025-06
Zoetis USD 2.46B 240M 2025-06


Bristol-Myers Squibb Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.